SSc-PAH has also been associated with CCL21 levels that have been shown to be elevated in patients with SSc and SSc-PAH, and to be elevated prior to the diagnosis of PAH, and elevated levels were associated with decreased survival [51]. The gene discussed is CCL21; the disease is systemic sclerosis.